72 Percent of Infants Immunized Against Respiratory Syncytial Virus

Medically reviewed by Carmen Pope, BPharm. Last updated on May 6, 2025.

By Elana Gotkine HealthDay Reporter

TUESDAY, May 6, 2025 -- In a recent study of a population of infants, published online May 6 in Pediatrics, 72 percent of infants were found to be immunized against respiratory syncytial virus (RSV).

Stephanie A. Irving, from Kaiser Permanente Center for Health Research in Portland, Oregon, and colleagues identified pregnant women aged 12 to 55 years with a live birth of ≥32 weeks of gestation from Sept. 22, 2023, through March 31, 2024. RSV vaccination was identified using electronic health records supplemented with data from the immunization information system. Nirsevimab administration through March 31, 2024, was identified among infants from eligible pregnancies. Infant RSV immunization, defined as exposure to antenatal vaccination or nirsevimab receipt, was examined.

Data were included for 36,949 eligible infants from 43,722 pregnancies. The researchers found that 72 percent of infants were immunized against RSV, with the highest estimates among infants born to non-Hispanic Asian mothers (84 percent). Disparities were seen by race, with coverage of 60 percent for infants born to non-Hispanic Black or non-Hispanic Middle Eastern or North African mothers. By birth month, coverage varied from 59 to 78 percent; nirsevimab was administered more often among infants born earlier in the season.

"Despite these successes, more than a quarter of infants enrolled in these health care systems remained unprotected from severe RSV, including 40 percent of infants born to non-Hispanic Black and non-Hispanic Middle Eastern or North African mothers," the authors write. "RSV product usage and coverage disparities should be explored in other populations."

Several authors disclosed ties to the pharmaceutical industry.

Abstract/Full Text

Editorial

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

Source: HealthDay

Read more

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Popular Keywords